Guidance on foods derived from plants produced using genome editing
USA
Feb 22, 2024
The U.S. Food and Drug Administration (FDA) has published "Guidance for Industry: Foods Derived from Plants Produced Using Genome Editing".
The purpose of this guidance is to clarify how FDA’s “Statement of Policy: Foods Derived from New Plant Varieties” (NPV policy) (57 FR 22984, May 29, 1992) applies to foods derived from new plant varieties produced using genome editing.
The Guidance reaffirms that the risk-based approach the FDA has taken for foods derived from new plant varieties also applies to foods from genome-edited plants. In addition, the Guidance describes two processes through which developers of new plant varieties may voluntarily inform the FDA of the steps they have taken to ensure the safety of foods from their genome-edited plant varieties: voluntary premarket consultations and voluntary premarket meetings.
For further information (in English), click on the Link